Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
can be 3 years.. but dosage needs to be different etc.
best way is to get some orphan status on vascepa.
that would mean 7 year exclusivity.
if vascepa reduces inflammation, im sure they can help with some rare diseases to get it added on the label which would mean 7 years extension.
wouldn't that be nice?
U guys worry too much. Patents will be extended via new indication, combo drug, extended XR, changes in formulation, etc. It always does, especially for $$$ drugs. Also, pyrr. We won. Why are you still here? Your DD didn't pan out. U lost. GET OVER IT LOL.
I know how u feel. I'm still answering questions at work for now 2 days in a row. As you can imagine, I'm the favorite person at my company.
JT stutters too much on unprepared remarks lol. Too happy I guess. Man what results! I was praying for 15 percent.
I took a video of myself commenting congratulation and will remember it forever. Lol.
When do we apply for EMA? European approval? That should double the sales.
12 just hit. Might even go to 20s eod.
.... u do not short that has this big of a potential LOL. 20billion in sales. Vascepa will raise prices now.
List of things to come.
1. Upgrades
2. Crazy media coverage.
3. More data anticipation
4. Partnerships
5. Multiple offers.
6. New indications, which will
7. Extend patents
8. Standard of care
9. Household name.
10. ITC ruling favorable
Wowwwww
11.50 ...
10 bucks now. Probably 30 in a month with this result. 25 percent! 50 bucks in a year.
West coast here in los angeles. OMG! Fuxx YES!!!
Go with omegavia. It is 120 of 500mg while pharmepa is 60. Don't let the 1000mg label fool you.
Hi everyone, probably first time posting here (nvm, i posted some year 2013 after checking). I have held shares of this company for over 5 years. Starting 3 months ago I started taking Vascepa.
I have no more ailing pain that I used to have constantly.
My skin feel much much better and stayed better.
Joint pain is virtually gone (knees and fingers)
I just feel whole lot better!
Trig went from 700s to mid 200s on gemfibrozil if i remember correctly, then after taking this, now it stands on 170s as of my last blood draw last week. My wife started it just today after seeing how great I felt haha (first and probably last time she follows after my lead)
I am a believer in this company and eagerly waiting for REDUCE-IT results.
I have pretty much read all posts going back few years and posting for the first time and want to THANK EVERYONE for their DDs.
Shouts to: Sam (love those scripts data!), Jesse (awesome DD), HD (the wise), Bio (the relentless). Of course there are way too many to mention but I thank all of you guys for great discussion board.
Good luck and may science prevail!
If we all win, I will join the LV party and I will pay for the second round since someone is buying the first if i remember correctly.
what is the OS of this stock?
nevermind.. got the info on the DD post.
Joe knows whether there are potential and serious partners around. He needs to kill reduce-it now if we dont have partner. We can hire contract sales with monry saved and break even b4 running out of cash. Dont forget that we have patents to 2030. Marine is worth more than zero.
Why would you need patents for it? we already have a whole bunch. We are good until 2030.
Someone can't just make generic Vascepa for DES when we have patent for Marine indication. Its the same drug. Anyways, with our management, this is a pipe dream... just like ANCHOR.
I would absolutely be SHOCKED if we get any kind of label revision that everyone is hoping for.
I just want DEC to be over with so we can find that partner with Marine and possible REDUCE-IT.
What i think we should be doing.
JOe should give time frame for possible partnership, say until 1st Q of 2014. If we don't find partner, we need to kill R-IT and massively hire sales and get this to breakeven status b4 we go BK.
We will NEVER go break-even with 140 sales. NEVER.
Joe should know if we are partner-able currently.... if we have no one interested, we need to hire GS and see if they can find one. if they still can't find partner, Joe needs to kill REDUCE-IT and contract out sales force to at least 500 people and start direct to consumer ads. Killing R-IT can support additional 350 people imo.
Killing R-IT in the long run might work out anyways. Jelis didn't lower trigs all that much for the 200+ population. I have my doubts about our outcome study. What if we end up getting A-fib on the long run study???? It might be good in the long run to push Marine for 17 whole years and make billions.
No i was actually thinking of running a phase 2, dosage escalation trial etc with perhaps 300 people, 100 on placebo, 100 on 2g, 100 on 4g. if successful, stock will run to 20s.
we should always have some sort of pipeline and this sounds very promising. Of course this will take couple years to complete but hey, it is what it is.
I think AMRN should submit trial design to FDA for dry eyes. that should get much interest from WS. Imagine the potential. I don't know anyone who doesn't have dry eye in SO CA.
Everyone is selling in anticipation of horrible CC. Joe will say we have three options!!!! sell, partner, or GIA! He will have no clear plan on how to make this company into a profitable company.
Thats why we are going down daily.
We had Niacin that sold 1B.
We have Lovaza selling 1B.
There is NO reason why Vascepa can't do the same.
Just because Crestor came around, Lipitor didn't die.
Lipitor is generic and yet Crestor is selling BIG.
We just need a dam fxxxcking partner that has a large sales.
Joe needs to come out and say:
Partnering will be our #1 priority from here and on and we are currently in discussion with numerous companies regarding partnering and that we will have one by end of the year.
There is ZERO chance we can survive on our own with 140 sales... ZERO chance. We need a partner that can and will market this with at least 500 reps. Even if we have to partner with 2nd tier pharma, we have to get something going to give future hope.
ORRRRR
If we have ZERO interested party, JOE should admit so and kill Reduce-IT and with that savings, hire additional 350 sales and market this until we are break even. Killing R-IT should be enough money to support 500 people with 80m dollar loss projection for 2014. I project we can go break even by mid 2015.
At current stock prices, we are almost at CASH with MARINE indication worth almost ZERO. How the heck did we get here? in all honesty, i thought we would be at $5 even with failed ANCHOR.
Does amrn even know about these events? U can use theseon type a meeting.
Agreed. $2 to $3 with another $2 or so with reduce-it if successful. I'll take that now and move on from this nightmare.
U mean to tell me he didn't dilute 5 percent and got the loan? what an IDIOT! excuse my language. We would be so much better right now if we didn't have that loan.
What a jackass. He must be fired and his resume must state "He drove one of the most promising drug into almost nothing and got paid millions for it."
Seriously though, we must find a partner using whatever means necessary. That is the only way we can survive.
It seems like we should be focusing on firing JOE first.
There is no way this will sell that low. I can think of many ways this can succeed. You must be kidding at $2 to $3.
We can find partner to apply for EU and give that away for favorable term for funding R-IT and getting upfront cash to market US.
Or we can share w/ world rights, plus tier royalties in US etc etc etc.
Reduce-IT can lower CV chance by over 15 percent and give us the best drug ever etc.
first thing is first. JOE must be fired. His EGO and his GOD complex is killing this company.
Hire me and I promise to get this rolling and I will work for ZERO salary. Unbelievable the greed of JOE.
what was the subgroup baseline trig for jelis?
did they compare those over 200 on the placebo vs those who started EPA at 200?